1. "Sarcoma Service"
  2. "Mary Keohan"
Formats
  1. Meeting Abstract (58)
  2. Journal Article (57)
  3. Editorial (1)
Groups
  1. Department of Medicine (116)
  2. Sarcoma Service (116)
  3. Solid Tumor Oncology Division (116)
  4. GSK Faculty (72)
  5. Tow Center for Developmental Oncology (TCDO) (72)
  6. Hematologic Malignancies, Division of (64)

More Groups

People
  1. Mary Keohan (116)
  2. Mark Dickson (68)
  3. William Tap (68)
  4. Mrinal Gounder (66)
  5. Sandra D'Angelo (63)
  6. Cristina Antonescu (49)

More People

Years
  1. 2024 (1)
  2. 2023 (8)
  3. 2022 (17)
  4. 2021 (2)
  5. 2020 (6)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (56)
  2. Clinical Cancer Research (11)
  3. Sarcoma (5)
  4. Annals of Oncology (4)
  5. Annals of Surgical Oncology (4)
  6. Cancer (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (58)
  2. American Association for Cancer Research (12)
  3. Elsevier Inc. (7)
  4. Oxford University Press (7)
  5. Springer (7)
  6. Hindawi Publishing Corporation (5)

More Publishers

Results (116)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Kelly, C.; Movva, S.; Nacev, B. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma
    Meeting Abstract

    Lacuna, K. P.; Lee, S. M.; Ge, L.; Druta, M.; Conley, A. P.; Keohan, M. L.; Agulnik, M.; Burgess, M. A.; Chalmers, A. W.; D'Amato, G. Z.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Randomized phase II trial of sunitinib or cediranib in alveolar soft part sarcoma
    Editorial

    Nguyen, J.; Takebe, N.; Kummar, S.; Razak, A.; Chawla, S. P.; George, S.; Patel, S. R.; Keohan, M. L.; Movva, S.; O'Sullivan Coyne, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • DICER1-associated anaplastic sarcoma of the kidney with coexisting activating PDGFRA D842V mutations and response to targeted kinase inhibitors in one patient
    Journal Article

    Antonescu, C. R.; Reuter, V. E.; Keohan, M. L.; Hwang, S.; Chi, P.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save